Healthcare -
Biotechnology - NASDAQ - US
$ 7.77
11.3 %
$ 10.1 M
Market Cap
-0.27
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
525.67%
EBIT
Estimate
--116.93%
Net Income
Estimate
41.42%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Ensysce Biosciences, Inc.
ENSC has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart ENSC
EBIT FORECAST
EBIT Forecast Chart ENSC
NET INCOME FORECAST
Net Income Chart ENSC